John Beyer, MD. Professor of psychiatry, Duke University Medical Center. Durham, NC. Dr. Beyer has consulted for Express Scripts. Relevant financial relationships listed for the author have been mitigated.
Susan Lehmann, MD.
Patricia B. and William T. Bright Professor in Mental Wellness. Clinical director, Division of Geriatric Psychiatry and Neuropsychiatry; director, geriatric psychiatry clinic, Johns Hopkins Hospital. Associate professor of psychiatry and behavioral sciences, Johns Hopkins University School of Medicine. Baltimore, MD. Dr. Lehmann has no financial relationships with companies related to this material.
M. Katherine Shear, MD
Marion E. Kenworthy Professor of Psychiatry at Columbia School of Social Work and Vagelos College of Physicians and Surgeons, New York, NY.
Dr. Shear has no financial relationships with companies related to this material.
Talia Puzantian, PharmD, BCPP.
Deputy editor for The Carlat Addiction Treatment Report. Professor, Keck Graduate Institute School of Pharmacy. Claremont, CA.
Dr. Puzantian has no financial relationships with companies related to this material.
Brian Fuehrlein, MD, PhD.
Addiction psychiatrist. Associate professor of psychiatry, Yale University. Director of the psychiatric emergency department at VA Connecticut. West Haven, CT.
Dr. Fuehrlein has no financial relationships with companies related to this material.
Hanni Flaherty, LCSWR, PhD, CASAC
Assistant Professor and Chair of Advanced Clinical Practice, Yeshiva University. President and Clinical Director, Collaborative People Clinical Group. New York, NY.
Dr. Flaherty has no financial relationships with companies related to this material.
Meghan Rose Donohue, PhD.
Instructor in Psychiatry, Division of Child and Adolescent Psychiatry, Washington University School of Medicine. St. Louis, MO.
Dr. Donohue has no financial relationships with companies related to this material.
Julian Ford, PhD, ABPP
Professor, Department of Psychiatry, University of Connecticut. Farmington, CT. Director, The Center for the Treatment of Developmental Trauma Disorders, a part of the National Child Traumatic Stress Network (www.nctsn.org).
Dr. Ford has no financial relationships with companies related to this material.
Dr. Arroyo has no financial relationships with companies related to this material.
Paula C. Zimbrean, MD, FAPA, FACLP
Associate professor of psychiatry and surgery (transplant), Yale University School of Medicine; Chair, Transplant Psychiatry Special Interest Group, Academy of Consultation Psychiatry. New Haven, CT.
Dr. Zimbrean has consulted for Ultragenyx and Vivet Therapeutics, and has consulted and advised for Alexion. Relevant financial relationships listed for the author have been mitigated.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
